✦ LIBER ✦

Correction to "A Novel Aminotetralin-Type Serotonin (5-HT) 2C Receptor-Specific Agonist and 5-HT2A Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses"

Book ID: 121860533
Publisher: American Society for Pharmacology and Experimental Therapeutics
Year: 2014
Tongue: English
Weight: 48 KB
Volume: 349
Category: Article
ISSN: 0022-3565
DOI: 10.1124/jpet.114.06er14

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Novel Aminotetralin-Type Serotonin (5-

A Novel Aminotetralin-Type Serotonin (5-HT) 2C Receptor-Specific Agonist and 5-HT2A Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses

✍ Canal, C. E.; Morgan, D.; Felsing, D.; Kondabolu, K.; Rowland, N. E.; Robertson, 📂 Article 📅 2014 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 851 KB

Agonist and antagonist actions of yohimb

Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

✍ Mark J. Millan; Adrian Newman-Tancredi; Valérie Audinot; Didier Cussac; François 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 1 views

Herein, we evaluate the interaction of the ␣ 2 -AR antagonist, yohimbine, as compared to fluparoxan, at multiple monoaminergic receptors and examine their roles in the modulation of adrenergic, dopaminergic and serotonergic transmission in freelymoving rats. Yohimbine displays marked affinity at hum

P.3.d.004 F15063, a novel antipsychotic

P.3.d.004 F15063, a novel antipsychotic with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties: I. Receptor affinity and efficacy in vitro and activity in neurochemical and neuroendocrine tests in rodents

✍ A. Newman-Tancredi; M.B. Assié; J.C. Martel; C. Cosi; P. Heusler; L. Bruins Slot 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB